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Abstract: 
The muscle-specific kinase MuSK is part of an agrin receptor complex which 
stimulates tyrosine phosphorylation and drives clustering of acetylcholine receptors (AChRs) 
in the postsynaptic membrane at the vertebrate neuromuscular junction. MuSK also regulates 
synaptic gene transcription in subsynaptic nuclei. Over the past few years decisive progress 
has been made in the identification of MuSK effectors, helping at understanding its function 
in the formation of the NMJ. Alike AChR, MuSK and several of its partners are the target of 
mutations responsible for diseases of the NMJ, such as congenital myasthenic syndromes. 
This minireview will focus on the multiple MuSK effectors so far identified that place MuSK 
at the center of a multifunctional signaling complex involved in the organization of the NMJ 
and associated disorders. 
 
Introduction 
 The function of chemical synapses is based on the accumulation of ligand-gated 
channels or receptors for neurotransmitters in the postsynaptic membrane domain. At the 
neuromuscular junction (NMJ), nicotinic AChR accumulates in the crests of the postsynaptic 
membrane with a surface density of 10-20,000/µm2 directly beneath the nerve terminal (reviewed 
in 1). Extracellular, transmembrane and cytoplasmic proteins, which have structural, adhesive 
and signaling roles, coaggregate with AChRs in the postsynaptic specialization. The synaptic 
specialization extends to the basal lamina which is locally enriched in specific isoforms of 
laminin, in perlecan and acetylcholinesterase (AchE, EC 3.1.1.7) (reviewed in 2). The synaptic basal 
lamina also contains two major factors expressed and secreted by motor nerves, agrin (3) and 
neuregulins (NRG)  (reviewed in 4), which are both implicated in synapse formation and 
maintenance (reviewed in 1, 5). NRG-1 activates ErbB receptors (Receptor Tyrosine Kinase 
belonging to the EGF receptor family) in the postsynaptic membrane and is thought to trigger 
transcription of AChR and other synaptic genes. Agrin is a large heparansulfate proteoglycan, 
first isolated by McMahan and colleagues from Torpedo electric organ, on the basis of AChR 
aggregating activity in vitro (3). Several agrin isoforms that differ in their capacity to induce 
AChR clustering are generated by alternative splicing, the most active forms being expressed 
by motoneurons during embryogenesis precisely during the innervation phase of muscle 
development (reviewed in 6). Most interestingly, ectopic postsynaptic specializations are induced in 
innervated myofibers following injection and expression of plasmids coding for neural agrin 
(7). The other important component for the differentiation of the NMJ is MuSK, a receptor 
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tyrosine kinase specific for muscle cells, (8, 9) expressed and concentrated in the postsynaptic 
membrane in Torpedo electrocyte and in skeletal muscle (8, 9, 10). Mice deficient for MuSK or 
agrin have similar phenotypes and lack normal neuromuscular synapses at birth (11, 12). These 
data with previous experiments showing that MuSK is activated by agrin, lead to postulate 
that MuSK is a component of an agrin receptor complex. Agrin was initially believed to 
promote the clustering of AChRs at the NMJ without major effects on transcriptional 
regulation. However, several studies suggest that agrin could also stimulate the transcription 
of synaptic genes and that MuSK is required for synapse-specific transcription (7, 13-20).  MuSK-
deficient mice also disclose presynaptic defects in addition to postsynaptic ones, indicating 
that MuSK activation is also required for presynaptic differentiation. This process involves 
retrograde signals so far unidentified.  
Despite many efforts, the direct physical interaction between MuSK and agrin has so 
far not been clearly established and the mechanism of activation of MuSK remains obscure. 
An associated component selectively expressed in skeletal muscle cells, termed MASC 
(Muscle-Associated Specific Component), has been postulated as coreceptor for agrin to 
activate MuSK (21). MASC has yet to be identified. Coligands for agrin or posttranslational 
modifications (glycosylation) either of agrin or of the ectodomain of MuSK could also be 
envisaged as cofactors for agrin activation of MuSK. 
The pleiotropic role of MuSK in synaptic differentiation likely relies on its interaction, 
either direct or indirect, with a wealth of downstream effectors. In the last few years, several 
partners of MuSK have been reported, sheding some light onto the mechanisms of action of 
MuSK. An integrated view of these various mechanisms, taking into account the most recent 
discoveries in the field, is however still pending. In this review we summarized recent 
advances in the function of the MuSK complex as a multifunctional platform regulating 
synapse formation and/or maintenance.  
 
The MuSK signaling pathway involves rapsyn and tyrosine phosphorylations 
 
Agrin stimulates the dimerization (22) and the kinase activity of MuSK which is 
essential for clustering of AChRs (23). Signaling triggered from MuSK activation depends 
upon the phosphorylation of a tyrosine residue (Y553) in the juxtamembrane consensus 
recognition site (NPXY) for phosphotyrosine binding domain-containing proteins (18, 24) 
(Figure 1). This phosphotyrosine is required to recruit downstream signaling components 
involved in many aspects of MuSK signaling, including tyrosine phosphorylation and AChR 
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clustering as well as synapse-specific transcription (18). Furthermore, agrin causes rapid 
activation of Src-related kinases and tyrosine phosphorylation of AChR β and δ subunits (25), 
the phosphorylation of β being required for efficient AChR clustering (26). Tyrosine 
phosphorylation as well as Src and Fyn kinases are necessary for cluster stabilization (27). 
However, MuSK kinase domain activation and the resulting phosphorylation of AChR 
subunits are not sufficient for AChR clustering, indicating that AChR phosphorylation is not 
the sole trigger of the clustering process (23).  
Rapsyn (Receptor-associated protein at the synapse), the 43-kDa cytoplasmic 
peripheral membrane protein associated with AChRs in the postsynaptic membrane (reviewed in 5) 
is an essential player in AChR aggregation. Rapsyn-deficient mice die at birth and, like 
MuSK mutants, lack all-kown features of postsynaptic differentiation, in particular AChR 
aggregates (28). In these mutants, MuSK normally accumulates at the central region of muscle 
fibers, indicating that rapsyn is a required intermediate in the pathway that couples MuSK 
activation to AChR clustering, possibly by recruiting synaptic components to a MuSK-
containing scaffold (29). Unlike the ectodomain of all other receptor tyrosine kinases simply 
mediating ligand binding, several reports point to an additional role of the ectodomain of 
MuSK in AChR clustering (18, 24, 28). Mapping domains on MuSK necessary for its interaction 
with rapsyn indicate that sequences in and near the fourth IgG-like domain (see Figure 1) are 
required for association with rapsyn through a putative protein RATL (Rapsyn Associated 
Transmembrane Linker) to mediate AChR aggregation in quail QT-6 cells (24, 29). Examination 
of agrin-inducing signaling events in rapsyn-deficient myotubes reveals that the agrin-induced 
MuSK activation occurs normally, whereas MuSK-dependent phosphorylation of AChR (and 
AChR clustering) does not occur. AChR phosphorylation is thus rapsyn-dependent. Src 
kinase, the major kinase phosphorylating AChR has been shown to be associated with rapsyn 
(30, 31). Rapsyn may thus function as a scaffolding protein presentating a MuSK-activated Src-
related kinase to the AChRs. 
 
MuSK triggers the clustering of synaptic proteins via actin cytoskeleton reorganization 
Convergent studies highlight the participation of actin in the process of AChR 
aggregation following agrin activation of MuSK. Agrin stimulation results in actin 
polymerization and translocation of the actin regulatory protein cortactin to postsynaptic sites 
(32). Moreover, latrunculin A, an inhibitor of actin polymerization blocks agrin-induced AChR 
clustering in myotubes (32). The Rho GTP-ases Rac/Cdc42, two ubiquitous monomeric small 
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GTPases regulating actin organization, are required for agrin-elicited clustering of AChRs in 
myotubes (33). Furthermore, Rac and Rho GTP-ases play distinct but complementary roles in 
the mechanism of AChR clustering. Rac is necessary for the initial phase of formation of 
microclusters, and Rho required for their subsequent condensation into full-size AChR 
clusters (34).  
The recent discovery of several MuSK effectors have shed some light on the 
molecular events downstream of agrin-induced MuSK activation (Figure 2). Interestingly, 
several of these effectors are involved in actin cytoskeleton organization. In addition to the 
MuSK kinase activity, a nonreceptor tyrosine kinase (NRTK) activity placed downstream of 
MuSK is necessary for AChR clustering. Pendergast and collaborators (35) hypothesized a role 
for Abelson tyrosine kinases (Abl) in synapse formation and reported the requirement of these 
proteins in agrin-induced AChR clustering in vitro. Abl1 and Abl2 (also known as Abelson 
and Arg respectively) define a family of NRTK characterized by several domains, including 
SH2 and SH3, a tyrosine kinase and a unique C-terminal actin-binding site. Abl kinases 
regulate actin organization and presynaptic axon guidance (36). Abl kinases are localized to the 
postsynaptic membrane of the developing NMJ. MuSK and Abl kinases effected reciprocal 
tyrosine phosphorylation and formed a complex upon agrin engagement. However, the 
binding site for Abl kinase on the cytoplasmic domain of MuSK remains to be determined. 
The authors proposed that Abl kinases amplify initial signaling and AChR clustering through 
tyrosine phosphorylations and stabilize clusters via induction of synaptic actin network (35).  
Using the yeast two-hybrid system with the cytoplasmic region of MuSK as a bait, 
Mei and collaborators (37) identified Dishevelled 1 (Dvl), a scaffolding protein originally 
discovered in Drosophila that is implicated in the development of coherent arrays of polarized 
cells via the Wnt signaling pathway. Dvls are cytoplasmic proteins constituted of three 
domains : DIX (Dishevelled-Axin), PDZ (Postsynaptic density/Disc large/ZO-1) and DEP 
(Dishevelled-Egl-10-Pleckstrin). The authors demonstrated that Dvl binds to both the 
juxtamembranous and kinase domains of MuSK through its DEP domain. However, this 
association is independent of MuSK phosphorylation and the disruption of the MuSK-Dvl 
interaction has a modest effect (≈ two-fold decrease) on agrin-induced AChR clustering. Dvl 
also interacts with the serine/threonine kinase PAK1 (p21-Activated Kinase), which becomes 
activated in myotubes in response to agrin. PAK1 is an effector of Rac and Cdc42 in actin 
reorganization. Dvl, by forming a scaffold with MuSK and PAK1, would thus regulate AChR 
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clustering mediated by agrin (37). Yet, the confirmation of the role of Dvl in the formation of 
the NMJ in vivo is awaited. 
Another potentially important signaling component in the agrin/MuSK pathway is 
geranylgeranyltransferase 1 (GGT, EC 2.5.1.10). Double hybrid experiments shown that the α 
subunit of GGT interacts with the kinase domain of MuSK (38). Agrin causes rapid increase in 
tyrosine phosphorylation of GGT, and inhibition of either GGT expression or of GGT activity 
prevents muscle cells from forming AChR clusters in response to agrin. GGT inhibitors 
prevent agrin-induced activation of Rac1, Cdc42 and PAK1 in myotubes. Moreover, 
transgenic mice expressing an inactive GGT mutant still able to bind MuSK, exhibit NMJ 
defects. Strictly, these data indicate that prenylation (a posttranslational modification of 
proteins catalized by GGT confering membrane targeting) of key components of the MuSK 
signaling pathway, for example Rac, is necessary for AChR clustering. Since the MuSK/ 
GGT association is independent of MuSK phosphorylation, a direct demonstration of the role 
of MuSK/ GGT interaction is still pending.  
Evidence for a regulation of AChR clustering by the tumor suppressor APC 
(Adenomatous Polyposis Coli), an actin-binding protein, has been reported (39). The APC 
protein has been found in several subcellular compartments of mammalian and drosophila 
cells, including the cytoplasm, nucleus and adhesive junctions. APC colocalizes with AChRs 
in the postsynaptic membrane of the NMJ and directly interacts with the β subunit of AChRs, 
helping to localize them to the actin cytoskeleton. Another actin-binding complex, the 
utrophin glycoprotein complex, is specifically enriched in the postsynaptic membrane (reviewed in    
40). Although not directly involved in the early steps of the AChR clustering process, this 
complex could play a role in the stabilization of AChR clusters, possibly linking rapsyn to the 
actin cytoskeleton through dystroglycan (41). One component of the utrophin complex, the 
phosphoprotein dystrobrevin (42), a substrate for tyrosine kinases, is implicated in the stability 
of agrin-induced AChR clusters (43).  
Finally, the scaffolding protein, MAGI-1c, has been identified by a proteomic 
approach as a MuSK partner in the postsynaptic membrane in Torpedo electrocytes (44). 
MAGI-1c (45) is a member of the MAGUK family of scaffolding proteins involved in cell 
polarity and organization of signal transduction within cellular junctions, excitatory central 
synapses and the NMJ in Drosophila (reviewed in 46). Alike other MAGUKs associated with 
synapses i.e. the PSD-95/SAP90 and S-SCAM, MAGI-1c is composed of several protein-
protein interaction domains: a Guanylate Kinase (GUK) domain, two WW domains and six 
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PDZ domains. Each one of these domains potentially confers specific association with a large 
pannel of signaling, structural and cytoskeletal elements. MAGI-1c is localized at the Torpedo 
electrocyte cholinergic synapses and at the adult rat NMJs but was not detected in agrin-
elicited AChR clusters in myotubes, suggesting that MAGI-1c is not involved in the 
clustering mechanism. In line with this observation, pull-down experiments revealed that the 
PDZ 4/5 domains of MAGI-1c interact with the consensus C-terminal PDZ binding site of 
MuSK (Cartaud et al., unpublished observations), a site that is dispensable for its clustering 
activity in cultured muscle cells (24). Similarly, PSD-95 family proteins are not required for 
receptor clustering but are believed to be organizers of excitatory synapses, and are involved 
in synaptic plasticity (reviewed in 47). Likewise, MAGI-1c might be involved in the building up of 
specialized protein complex at the NMJ participating to the terminal differentiation of the 
NMJ.  
 
MuSK and the regulation of synaptic gene transcription  
Genes encoding AChR subunits, as well as utrophin, rapsyn, AChE and MuSK are 
selectively transcribed in myofiber nuclei localized beneath the nerve contact. Thus, synapse-
specific transcription is believed to participate in concentrating gene products at the NMJ 
(reviewed in 1, 48). NRG (4) acting through ErbB tyrosine kinase receptors in the postsynaptic 
membrane activates synaptic gene transcription via the Mitogen-Activated Protein Kinase 
(MAPK), c-jun NH2-terminal kinase  (JNK) and the Phosphatidyl Inositol-3 Kinase (PI3K) 
signal transduction pathways (see Figure 3). These pathways converge to the phosphorylation 
of the Ets transcription factor GA binding-protein (GABP) α/β. Phosphorylated GABP and 
JNK/c-jun activate transcription of the synaptic genes via GABP binding to the N-box, a 6-bp 
promoter segment CCGGAA that directs synapse-specific gene expression (reviewed in 48).  
 Two negative regulators of the NRG/ErbB pathway, the protein tyrosine phosphatase 
SHP2 and erbin, have been identified. SHP2 dephosphorylates and inactivates ErbB receptors 
in the postsynaptic membrane after NRG stimulation and attenuates the NRG-induced 
expression of the ε AChR promoter reporter gene in cultured myotubes (49). Erbin, associates 
with the C-terminus of ErbB2 through its PDZ domain and down regulates the MAPK 
signaling cascade stimulated by NRG, through inactivation of Ras (50).  
In addition to the NRG/ErbB pathway, several studies pointed to a role for agrin and 
MuSK in the regulation of synaptic gene transcription. Neural agrin or constitutively active 
MuSK cluster the ErbB receptors and stimulate transcription of AChR genes (7, 51). Recently, 
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Brenner and collaborators demonstrated that agrin-induced musk transcription is controlled in 
part by the NRG/ErbB pathway organized by agrin-MuSK and by a novel shunt path in which 
MuSK stimulates the activation of Rac and JNK in an independent manner of the NRG/ErbB 
pathway. Both pathways converge onto the the N-box in the musk and possibly other synaptic 
gene promoters (15). In fetal muscles, formation of postsynaptic-like sites and targeted gene 
expression begins to develop in the absence of agrin but depends on MuSK (19, 20). Given these 
data, MuSK appears to be not only involved in AChR clustering but also in the regulation of 
synaptic genes expression. Interestingly, Rac/Cdc42 appear to play a central role in 
agrin/MuSK signaling conducting both to synaptic gene transcription and AChR clustering 
(see Figures 2 and 3).  
 In a systematic search for MuSK partners in situ, Cartaud and collaborators  (52) 
identified the adaptor protein 14-3-3 γ, using a proteomic approach in purified postsynaptic 
membrane from Torpedo electrocytes. The 14-3-3 γ protein colocalizes with AChRs at the 
NMJ in rat muscles and coimmunoprecipitates with MuSK. 14-3-3 proteins constitute an 
emerging family of signaling molecules present in eukaryotic organisms involved in 
intracellular signaling (reviewed in 53). Among many functions in cell signaling, 14-3-3 proteins are 
major regulators of the MAPK and PI3K signaling pathways. Overexpression of 14-3-3γ in 
muscle cells specifically represses transcription of several synaptic genes including α, δ and 
ε-AChR subunits, utrophin (promoter A), rapsyn, and MuSK. The 14-3-3 proteins are known 
to interact and modulate the activity of Raf-1 (54). In myotubes in culture, 14-3-3 γ inhibits the 
activation of ε-AChR induced by constitutively active Raf-1, suggesting that it acts 
downstream of the NRG/ErbB pathway by blocking Raf-1 in an inactive conformation. 
Moreover, the expression of 14-3-3 γ in muscle fibers in vivo causes both the repression of 
synaptic genes transcription and morphological perturbations of the NMJ. Taken together, 
these data provide evidence that MuSK may serve as a scaffold to localize and concentrate 
14-3-3 γ close to the postsynaptic membrane. At this location,  14-3-3 γ, is prone to interact 
with signaling molecules of the NRG/ErbB cascade such as Raf-1 (see Figure 3). In many 
cases, the interaction of 14-3-3 proteins with their various partners is regulated by 
phosphorylation of serine residues in consensus sequences in the target proteins (reviewed in  55). 
Two such sequences have been identified in the cytoplasmic region of rat MuSK (52). An 
interesting hypothesis raised by these observations is that a signaling molecule, probably 
different from agrin, would regulate the MuSK/14-3-3 interaction, thereby regulating the 
synaptic transcription. 
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MuSK localizes asymmetric forms of acetylcholinesterase at the NMJ 
At the NMJ, AChE is mainly present as asymmetric forms in which three tetramers of 
catalytic subunits are associated with a structural collagenic tail named ColQ (reviewed in 2). The 
accumulation of the enzyme in the synaptic basal lamina strictly relies on ColQ. This 
mechanism is mediated by interaction between the collagenous domain of ColQ and perlecan, 
an heparan sulfate proteoglycan, which itself binds α-dystroglycan, a transmembrane 
glycoprotein of the dystrophin/utrophin complex  enriched at the NMJ. In the absence of α-
dystroglycan (56), perlecan and AChE do not colocalize with AChR. Also, in perlecan null 
mice, AChE is absent from the NMJ (57). These data suggest the requirement for the 
dystrophin/utrophin complex in clustering AChE at synaptic sites. However, recent studies 
indicate that the C-terminus of ColQ is required for AChE anchoring at the NMJ (58), 
suggesting that another protein might interact with AChE and contribute the specificity 
needed for synaptic localization. This protein has recently been identified as MuSK (59). MuSK 
and ColQ can be crosslinked in situ in Torpedo AChR-rich membranes. Both proteins 
colocalize and coimmunoprecipitate in COS-7 cells cotransfected with plasmids encoding 
MuSK and ColQ. Moreover, MuSK is required to form cell surface AChE clusters in cultured 
myotubes (59). Taken together, these observations suggest that a ternary complex containing 
ColQ, perlecan and MuSK is required for AChE clustering and demonstrate that MuSK 
dictates AChE synaptic localization at the NMJ. They also provide a rational molecular basis 
explaining certain forms of congenital myasthenic syndrome (CMS) associated with 
mutations in the C-terminal part of ColQ. Surprisingly, in these patients, the asymmetric 
forms of AChE are normally synthesized, assembled and secreted. Yet, no AChE accumulate 
in the synaptic cleft (reviewed in 60). The impossibility for these mutants of ColQ to bind efficiently 
with MuSK at synaptic sites is undoubtedly causal in these disorders. 
 
 
MuSK : a new target for autoimmune and genetic disorders at the neuromuscular 
junction 
 
Because of its importance in NMJ development and function, and alike AChR and 
other synaptic proteins, MuSK is a possible target for autoimmune and genetic disorders at the 
NMJ (61, 62). Myasthenia gravis is an antibody-mediated autoimmune disease of the NMJ 
caused, in the majority of patients, by the presence of auto-antibodies to AChR and the 
consecutive loss of AChRs in the postsynaptic membrane. In 70% of myasthenia gravis 
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patients seronegative for AChR-antibodies, circulating auto-antibodies to MuSK are present 
(63). These observations define immunologically distinct forms of the disease. The MuSK 
auto-antibodies were specific for the extracellular domains of MuSK and strongly inhibited 
MuSK function (63).  These antibodies are thus likely involved in the pathogenesis.  Other 
major disorders of the NMJ –the congenital myasthenic syndromes- caused by mutations in 
key components of the postsynaptic membrane such as AChR subunits and AChE (see above) 
have been reported (reviewed in 60). Recently, MuSK has been shown to be the direct target for 
mutations causing CMS associated with dramatic pre- and postsynaptic structural 
abnormalities and severe decreases in AChR ε-subunit and MuSK expression (62). Mutations in 
rapsyn, a downstream effector of MuSK, also caused myasthenic syndromes (review in 60). One 
could predict that novel mutations in MuSK will be discovered in myasthenic patients, and 
that MuSK effectors are potential molecular targets for neurological diseases at the NMJ. 
Understanding the fundamental molecular and cellular bases underlying MuSK function holds 
the promise of therapeutic approaches for treating these pathologies. 
 
 
 
Concluding Remarks 
The increasing knowledge of the MuSK effectors provide a coherent molecular basis 
to the functional complexity of MuSK, sustaining its pleiotropic function in NMJ formation. 
In the model proposed (Figure 2), upon stimulation by agrin, MuSK recruits Abl kinases 
which activate Rac/Cdc42 which would in turn stimulate PAK1 and other targets of activated 
GTPases. Dvl, owing to its interaction with MuSK and PAK1, functions as a scaffold 
molecule bridging the two proteins to form a signaling complex which leads to local actin 
reorganization, ultimately conducting to AChR clustering. In this context an important role 
for GGT would be to confer membrane localization of Rac/Cdc42, and thus basal Rac/Cdc42 
activation. However, the steps in agrin signaling between MuSK activation and actin 
cytoskeleton anchoring of AChRs via rapsyn are still incompletely characterized. 
Other key MuSK partners, 14-3-3 γ and ColQ fulfil different dedicated roles in 
synapse formation and/or maintenance, such as the regulation of synaptic gene expression and 
the localization of AChE, respectively. How these various molecules operate spatiotemporally 
and how the multiple signaling pathways are coordinated to orchestrate synaptic 
differentiation are important issues that should deserve future investigations. In this line, 
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MAGI-1c, the PDZ-containing scaffolding molecule associated with the C-terminus of MuSK 
is potentially central in the organization of the subsynaptic signaling complex. 
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Fig. 1 : Domain organization of the receptor tyrosine kinase MuSK 
 The ectodomain of MuSK contained four immunoglobulin-like domains (Ig-1 to Ig-4) 
and a region containing six phylogenetically conserved cysteine residues (C6 box). The first 
Ig-like domain is required for agrin responsiveness (interaction with agrin/MASC) whereas 
the fourth Ig-like domain and adjacent sequences are necessary for rapsyn/RATL interaction 
(see also Fig. 3). In the cytoplasmic region of MuSK, a recognition site NPXY for 
phosphotyrosine binding (PTB) domain –containing proteins as well as the ATP-
binding/kinase domain are both essential for activity. The C-terminal VXV consensus 
recognition site for PSD-95/Dlg/ZO-1 like (PDZ) domain –containing proteins is engaged in 
the binding of MAGI-1c. TM, transmembrane domain. 
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Fig. 2 : Model of the MuSK complex and downstream signaling pathways. 
The extracellular domain of MuSK accomodates binding sites for agrin (with the help 
of the putative muscle-associated specific component, MASC), RATL and ColQ. 
Cytoplasmic effectors Abl, GGT and Dvl interacting with MuSK activate Rac/Cdc42/PAK1 
leading to actin cytoskeleton reorganization and AChR aggregation, likely through APC. The 
juxtamembrane NPXY motif is required for MuSK signaling through putative PTB domain –
containing proteins. The scaffolding protein MAGI-1c which binds to the C-terminal 
consensus PDZ binding site of MuSK (VXV), potentially recruits multiple, yet unidentified, 
subsynaptic signaling molecules. Finally, the adaptor protein 14-3-3 γ regulates synaptic gene 
expression via inhibition of MAPK/PI3K signaling pathways (see Figure 3). The various 
molecules are not represented at scale. TM, transmembrane domain. 
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Fig. 3 : Model for transcriptional regulation of synaptic genes at the NMJ 
 The tyrosine kinase receptors ErbB 2/4 and MuSK trigger several signaling cascades 
that cooperate to initiate transcriptional activation of synaptic genes in subsynaptic nuclei.  
Activation of ErbB receptors by neuregulin (NRG) triggers both the MAPK and JNK 
pathways via Ras. This lead to the expression of c-Jun and to the phosphorylation of the Ets-
related transcription factor GABP that will activate transcription of synapse-specific genes 
through binding to the N-box (N). MuSK also induces activation of JNK via Rac/Cdc42, 
suggesting that the two pathways are connected. Inhibitory factors such as Erbin and SHP2, as 
well as 14-3-3γ interacting with MuSK, inactivate the ErbB signaling pathway. The question 
mark indicates a possible regulation of the MuSK/14-3-3 γ interaction by a still unknown 
signal either acting on MuSK or on another signaling molecule. The PI3K pathway is not 
indicated in the model. (Modified from refs. 15 , 48). 
 
 
 
 
 
 
